Halozyme Therapeutics has entered into collaboration and license agreement with Pfizer for the development and commercialization of subcutaneous biologics. The collaboration will focus on developing Pfizer biologics, leveraging Halozyme's ...
Tags: biologics, Halozyme Therapeutics, subcutaneous biologics, treatments